J 2010

Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic

STARÝ, Jan, Yahila JABALI, Jan TRKA, Ondřej HRUŠÁK, P. GAJDOS et. al.

Basic information

Original name

Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic

Name in Czech

Dlouhodobé výsledky léčby dětské akutní lymfoblastické leukémie v České republice

Authors

STARÝ, Jan (203 Czech Republic, guarantor), Yahila JABALI (203 Czech Republic), Jan TRKA (203 Czech Republic), Ondřej HRUŠÁK (203 Czech Republic), P. GAJDOS (203 Czech Republic), Hana HRSTKOVÁ (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution), B. BLAZEK (203 Czech Republic), J. HAK (203 Czech Republic), D. PROCHAZKOVA (203 Czech Republic), Z. CERNA (203 Czech Republic), P. SMISEK (203 Czech Republic), P. SEDLACEK (203 Czech Republic), V. VAVRA (203 Czech Republic), V. MIHAL (203 Czech Republic) and O. HRODEK (203 Czech Republic)

Edition

Leukemia, England, Nature Publishing Group, 2010, 0887-6924

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30209 Paediatrics

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

is not subject to a state or trade secret

Impact factor

Impact factor: 8.966

RIV identification code

RIV/00216224:14110/10:00051720

Organization unit

Faculty of Medicine

UT WoS

000274397700016

Keywords (in Czech)

Akutní lymfoblastická leukémie; děti; treatments results

Keywords in English

Acute lymphoblastic leukemia; children; treatment results

Tags

International impact
Changed: 20/4/2012 11:33, Mgr. Michal Petr

Abstract

V originále

Treatment of children with acute lymphoblastic leukemia(ALL) in the Czech republic was unified durind 1980s with BFM protocols. ALL BFM 90 No af patients 350. Ten -year overal survival 76,6+-2,3.ALL BFM95 380 pacients.Ten-year overal survival 80,2+-2,1

In Czech

Od 80 let se v České republice užívají k léčbě dětí s akutní lymfoblastickou leukémií BFM protokoly.Podle BFM 90 protokolu bylo léčeno 350 dětí a 10 leté celkové přežití bylo 76,6+-2,3 roku.Podle BFM 95 protokolu bylo léčeno 380 dětí, 10 leté přežití bylo dosaženo 80,2+-2,1 roku